The Discounted Cash Flow (DCF) valuation of INVO Bioscience Inc (INVO) is (844.69) USD. With the latest stock price at 0.83 USD, the upside of INVO Bioscience Inc based on DCF is -101503.9%.
Based on the latest price of 0.83 USD and our DCF valuation, INVO Bioscience Inc (INVO) is a sell. selling INVO stocks now will result in a potential gain of 101503.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.4% | 5.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (4,461.27) - (474.41) | (844.69) |
| Upside | -535667.0% - -57051.8% | -101503.9% |